Stocklytics Platform
Asset logo for symbol APLT
Applied Therapeutics
APLT59
$0.40arrow_drop_down1.92%-$0.00
Penny Stock
Asset logo for symbol APLT
APLT59

$0.40

arrow_drop_down1.92%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Applied Therapeutics (APLT) Stocklytics Forecast

Applied Therapeutics Inc (APLT) is a biopharmaceutical company that specializes in the development of novel therapeutics for the treatment of serious diseases. With a focus on precision medicine, APLT utilizes a targeted approach to develop therapies that address the underlying molecular mechanisms of various conditions. The company's pipeline includes potential treatments for diseases such as Galactosemia and Diabetic Cardiomyopathy, which have limited treatment options currently available.
When it comes to the stock price prediction for Applied Therapeutics Inc (APLT), analysts and AI-based forecasting models offer valuable insights. Based on the available data and market trends, there is a positive sentiment surrounding APLT's future stock performance. Analysts have provided price targets for APLT, with some predicting significant growth over the next few years.
add Applied Therapeutics to watchlist

Keep an eye on Applied Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Applied Therapeutics (APLT) stock?

Analysts have set a target price of $13.84 for Applied Therapeutics (APLT), based on forecasts from 14 analysts. The predicted price range extends from a high of $43 to a low of $2.25. This represents a potential increase of up to 10.47K% and a decrease of 452.83% from the current price of $0.41. These forecasts are as of 2019 Jun 10.
help

What are the analyst ratings for Applied Therapeutics (APLT) stock?

The analyst ratings for Applied Therapeutics (APLT) are distributed as follows: 2 analysts recommend buying, 2 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Applied Therapeutics .
help

What is the AI price prediction for Applied Therapeutics (APLT) stock?

At present, there is no AI or machine-learning-based price prediction available for Applied Therapeutics (APLT) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level